PIK3CA and cancer: Recently, mutations in PIK3CA (encoding the catalytic subunit of PI3K, P110α) were observed in multiple cancers, including brain tumors, further supporting the fundamental role of PI3K pathway activation in the pathogenesis of human cancer [15,16].